IFPMA Millennium Development Goals

In 2000, the Millennium Development Goals (MDGs) set out in motion a landmark political agenda from the highest levels of national governments to be achieved by 2015. Through eight overarching goals, governments and international organizations committed to improving the social and economic conditions especially in the world's poorest countries. A recent report from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) looked at several of these goals, which strongly relate to life science companies. Specifically, the report looked at goals related to: Reducing child mortality Improving maternal health Combating HIV/AIDS, Malaria and other diseases; and Creating a global partnership for development Since the MDGs' launch, many notable health successes resulted from coordinated actions by many contributors from public and private sectors and civil society. Pharmaceutical companies lead over 220 partnerships—a five-fold increase compared to a decade ago—to strengthen health systems and improve peoples' health in low- and middle-income countries, the IFMPA report notes. These partnerships address a wide range of diseases and focus on prevention, improvements in health system infrastructures, training, pharmaceutical R&D, and medicine and vaccine donations. Thus, industry plays an important role in advancing progress toward the health-related MDGs. Specifically, of these 220 partnerships: 20% focus on HIV/AIDS 16% focus...
Source: Policy and Medicine - Category: Health Medicine and Bioethics Commentators Authors: Source Type: blogs